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doi:10.1016/j.ejvs.2009.11.023Abstract Objectives: To evaluate the efficacy of a silver-coated vascular polyester graft in
the prevention of graft infection after inoculation with Staphylococcus aureus in a porcine
model.
Material and methods: Eighty-four pigs were randomly selected 1:1 to receive a silver-coated
or non-silver-coated 8-mm-wide polyester graft implanted end-to-end in the infrarenal aorta.
At the end of implantation, 106 colony forming units (CFUs) S. aureus in 0.3 ml suspension were
inoculated directly on the graft surface. Blood samples assayed for white blood corpuscles
(WBCs) and C-reactive protein (CRP) were taken before implantation and on the postoperative
days 2, 5, 7, 11 and 14. Two weeks after implantation, the perigraft swabs were analysed for
S. aureus or contaminants. CFUs of S. aureus were quantified and logarithmised. Student’s
t-tests, repeated measurement analysis of variance (ANOVA) and chi-square test were em-
ployed to compare the two grafts.
Results: All pigs developed graft infection. There were no statistically significant differences
between the silver-coated and non-silver-coated grafts in the quantity of S. aureus, macro-
scopic signs of infection and postoperative changes in the temperature, WBC and CRP.
Conclusions: Silverecoated polyester grafts failed to prevent graft infections after inoculation
with 106 S. aureus in 0.3 ml suspension in a porcine model.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Prosthetic vascular graft infection (PVGI) is a rare but
a feared complication in vascular surgery. Despite ongoing
advances in sterile surgical techniques and routine anti-
biotic prophylaxis, the frequency remains at 0.5e6% in9272447; fax: þ45 89273580.
m.dk (H. Gao).
ty for Vascular Surgery. Publishevascular graft implantations over the past 20 years, and it
is associated with considerable morbidity and 12e27%
mortality.1e4 The most common cause of PVGI is bacterial
contamination during implantation or in the postoperative
period. Staphylococcus aureus, which easily adheres to
and colonises graft surfaces such as biofilms, is a preva-
lent bacterium found in early vascular postoperative
infections.1,2,5d by Elsevier Ltd. All rights reserved.
Prevention of Primary Vascular Graft Infection 473The difficulties and expenses associated with the
treatment of PVGI have led to increased interest in
preventive measures. A potentially feasible approach is
antimicrobial vascular grafts, such as the silver-coated
graft.
Therefore, we evaluated the prevention by silver-coated
vascular polyester graft in primary vascular graft infection
in a porcine model.
Material and Methods
We used 84 two-month old female pigs in blocks of six
sisters. Three weeks before surgery, the pigs were caged
individually to acclimatise to the surroundings in the labo-
ratory, and fed with different diets containing fish oil,
sunflower oil and animal fat. Preoperatively, the pigs in
blocks of six sisters had a weight between 50 and 101 kg
(95% confidence interval (C.I.): 73 2.53) and were
randomly selected 1:1 to have a part of the infrarenal aorta
exchanged with a silver (Ag-acetate)-coated knitted poly-
ester graft or a non-silver-coated collagen-coated knitted
polyester graft. The random allocation was stratified by
blocks of six sisters and diet by a random number produced
by Epi Info 6. If one graft was chosen initially, the opposite
graft was used for the next operation of a sister on the
same diet. In addition, the animal keepers picked the pigs
in the cages blinded from this random allocation.
All the implanted grafts were inoculated with 106 colony
forming units (CFUs) of S. aureus ATCC 29213 in 0.3 ml
suspension, and estimated quantitatively after 14 days.
Blood samples were taken before operation and at day 2, 5,
7, 11 and 14 after implantation to measure white blood
corpuscles (WBC) and C-reactive protein (CRP). Post-
operatively, the pigs were monitored daily, including
registration of food and water intake, behaviour and
measurement of rectal temperatures with an electrical
thermometer.
Bacterial strain
The S. aureus strain ATCC 29213 used in this experiment has
been used in several infected animal models, including
PVGI studies.6,7,21 The strain was susceptible to methicillin,
oxacillin, gentamicin, ciprofloxacin, rifampicin, vancomy-
cin and cefoxitin, but resistant to penicillin.
Animal model
The pigs were anaesthetised with a mixture of zolamine
5 mgml1, butorphanol 1 mgml1, ketamine 10 mgml1
and xylazin 2 mgml1 using 1 ml mixture per 15 kg body
weight. Anaesthesia was maintained by intravenous infu-
sion of propofol, 10 mg kg1 h1, fentanyl 0.025 mg kg1 h1
and ventilation with 60% oxygen throughout the operation.
All the pigs were given 1.5 g cefuroxime intravenously just
before incision. The pigs were placed in the dorsal position,
and the abdominal aorta was exposed through a 25e30-cm-
long midline laparotomy under aseptic conditions. After
intravenous administration of 5000 IU bolus of heparin, the
aorta was clamped just below the left renal vein and just
above the aortic bifurcation. The lumbar and inferiormesenteric arteries were clipped and cut. The infrarenal
aorta was replaced with one of the two mentioned poly-
ester grafts, approximately 5 cm long and 8 mm wide, by
end-to-end anastomoses using 4/0 polypropylene sutures.
After haemostasis was secured, the surfaces of the grafts
were directly inoculated with 106 CFUs of S. aureus in
0.3 ml suspension using a 1-ml syringe. The perigraft tissue
was closed around the graft, so the bacterial suspension
was hampered. Hereafter, the retroperitoneum and
abdominal wall were closed in layers with standard surgical
techniques.
Postoperatively, the pigs daily received intramuscular
injections of flunixin 100 mg once and buprenorphine
0.6 mg twice or thrice for pain relief until the third post-
operative day.
Sampling from graft and surroundings
After approximately 14 days, the grafts were removed
through the previous incisions under aseptic conditions.
Signs of graft infection as the status of perigraft tissue,
exudation, pus and anastomoses were recorded. Swabs
from the perigraft area were put into Stuarts transport
medium for later bacterial identification and quantitative
analysis.
Bacteriologic studies
The swabs were vortexed in 1 ml saline for 2 min. Fifty
microliters of the suspension were diluted serially, from
102 to 106, and incubated aerobically at 35 C overnight.
The final quantitative results of bacteria in the swabs were
expressed as the number of CFUs.
The study was approved by the National Animal Research
Inspection working for the Danish Ministry of Justice.
Statistical analysis
The number of CFUs was logarithmised to achieve a normal
distribution. Statistical comparisons between different
grafts were performed with Student’s t-test and linear
regression analysis adjusting for weight, diet and random-
isation block. Serial changes of WBC, CRP and rectal
temperature were compared using repeated measurement
ANOVA. For categorical variables, chi-square tests were
performed. Statistical significance was assigned when
p values were less than 0.05 SPSS 15.0 was used as statis-
tical software (SPSS Inc., Chicago, IL, USA).
The size of the study was based upon a power calcula-
tion to detect a 33% difference in the frequency of graft
infections with an 80% power and a 5% risk of a type 1 error
assuming 90% of the pure polyester grafts became infected.
Results
Seventy-eight pigs (93%) survived until scheduled grafts
were explanted 14 days after bacterial inoculation. One pig
was euthanised due to thrombosis on day 1 after operation
because of a technical error during operation. Three pigs
were euthanised in 1 or 2 days after the primary operations
because of being incapable of standing up and eating, but
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Figure 1 Flow chart over the included pigs.
Table 2 Linear regression analysis of pure polyester
grafts and Silver grafts with nature logarithmised bacterial
numbers in swab [ln(CFUs)] as the dependent variable
adjusting for weight, randomisation block, and diet.
Dependent variable Standardised coefficients P value
ln(CFUs) in swab Graft type 0.03 0.78
Diet 0.17 0.1
Weight 0.23 0.12
Block 0.2 0.19
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the 7th and 9th postoperative day, two were euthanised
due to intestinal volvulus and spinal cord ischaemia,
respectively, but at autopsy all data were obtained and
included in the analyses (Fig. 1). Two re-operations were
performed in the first postoperative week because of
wound rupture and ileus.
All the silver-coated and non-silver-coated grafts were
still infected with S. aureus after 2 weeks. All of them
presented macroscopic signs of infection and harboured S.
aureus after 14 days or at autopsy. The differences of
logarithmically quantified S. aureus CFU on swabs and
macroscopic signs, such as perigraft pus, necroses and
exudates, between two types of grafts were not statisti-
cally significant (Table 1). Adjustment for the mentioned
potential confounders did not reveal any significant
differences between the two graft types in the logarithmic
quantities of the bacteria on the swabs (Table 2). The graft
patencies were maintained in all the 80 analysed pigs. TheTable 1 Overview of the macroscopic signs and the
bacteriologic quantitative culture results at 14 days after
inoculation of 106 S. aureus to aortic silver-coated and non-
silver-coated grafts.
Silver-coated
graft
Non-silver-
coated graft
P value
Pusa 26 28 0.81
Necrosesa 40 40
Exudatesa 35 36 1.0
Enteric erosiona 0 0
Anastomoses
disruptiona
0 0
Graft patencya 40 40
Intra mural
thrombusb
36 32 0.12
ln(CFUs)c 95%CI 12.96 0.63 13.11 0.59 0.73
a samples were 40 silver-coated graft and 40 non-silver-
coated graft.
b samples were 36 silver-coated grafts and 35 non-silver-
coated grafts.
c nature logarithm of the CFU in the swabs.materials of grafts from the 71 pigs (85%) were harvested,
but all of them except two non-silver-coated grafts pre-
sented a thick intra mural thrombus obviously (Table 1). At
microscopic examination, this layer showed to contain
Gram-positive cocci and fibrin (Fig. 2). No anastomotic
disruptions and enteric erosions were seen.
Twelve out of 84 pigs did not present haematologic
results because of instrumental failure. The haematologicFigure 2 Macroscopic examination of the intra mural
thrombus developing during severe graft infection of knitted
polyester grafts consisting of S. aureus and fibrin, suggesting
bacteria can migrate through a polyester graft and become
a potential source of septic embolia. (a) Hematoxylin-eosin
staining (b) Gram staining (a mass of S. aureus on arrow marks
area).
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remaining pigs (76%) were used in the statistical analyses.
The postoperative changes over time of peripheral WBC,
CRP and body temperature, were similar (PZ 0.43;
PZ 0.59; PZ 0.85, respectively) in silver-coated and non-
silver-coated grafts. The mean WBC increased continuously
from the 5th postoperative day to 14th postoperative day in
both groups without any statistical difference (PZ 0.27).
The mean curve of CRP showed a sharp rise from day 0 to
day 7, also without statistical difference (PZ 0.58). The
changes in mean values of rectal temperature, WBC and
CRP in the 14 postoperative days are recorded in Fig. 3.Figure 3 Changes over time in mean temperature, WBC, and
CRP between the two graft types.Discussion
This study is the largest randomised animal study
attempting to investigate the prophylactic efficacy of
silver-coated graft to prevent PVGI. Our experiment
showed that silver-coated graft cannot prevent such
infections, if inoculated with 106 CFUs S. aureus in 0.3 ml
suspension. In fact, both silver-coated and non-silver-
coated grafts were all equally infected with no signs of
different degrees of infection. However, this may not be
the same if the inocula were less than 106 CFUs of
S. aureus. The dose used in this study was based upon
a pilot study with inocula ranging from 50 000e106 CFU of
S. aureus in 0.3 ml suspension, indicated that 106 CFUs of
S. aureus was needed to get 90% graft infections.
In most previous studies in using animal models, the
inoculations were from 1 ml of 107 CFU ml1 to
109 CFU ml1 S. aureus.7,11,13e15,21e23 The reason for using
such high concentrations was to achieve a sufficient inci-
dence of infected cases. According to the guidelines of the
National Committee for Clinical Laboratory Standards,
using 106e108 CFU ml1 bacteria is accepted for antibac-
terial activity testing.23 A previous work showed that 50 ml
of 1.8 104 CFU ml1 (900 CFU) S. aureus could affect five
out of six dogs with PVGI; however, preoperative antibiotic
prophylaxis was not used.24 In another study, the inocula-
tion with 1 ml of 105 CFU ml1 and 107 CFU ml1 S. aureus
failed to develop PVGI when using antibiotic prophylaxis.22
In many clinical practices, the prophylactic preoperative
antibiotic administration during primary vascular graft
implantation and postoperatively has become a routine.
However, the postoperative antibiotic treatment was not
used in our study because it is not routinely performed in
Denmark.
Silver-coated medical devices have for 30 years been
produced to prevent device-associated infection. Silver ion
is probably a useful antibacterial substance with remark-
ably low human toxicity.8,9 The antimicrobial action of
silver is related to the silver cation released from inorganic
silver salts and complexes by binding to bacterial DNA to
prevent replication.9 In contrast to antibiotics, silver has
not been reported to develop bacterial resistance.10 Silver
coating has been applied to a variety of prostheses, such as
bladder catheters, vascular catheters, peritoneal catheters
and vascular grafts.9 Although there are so far no stand-
ardised data confirming antimicrobial activity of the silver-
coated graft, a commercially available silver-coated
vascular polyester graft to treat PVGI is used clinically.11
476 H. Gao et al.Some in vivo and in vitro experiments suggest the silver-
coated graft may be associated with a significant reduction
in bacterial growth.12,13 Nevertheless, the conclusions
obtained from following studies seem totally contradictory.
Goeau-Brissonniere et al.14 inoculated 1 ml of 6 109
CFU ml1 S. aureus to infect infrarenal aortic polyester
grafts in dogs, where they found infection in six of six and
five of six using polyester (control) and silver-coated grafts,
respectively, but none of the six rifampicin-soaked grafts
harboured S. aureus. Similar results were found in a study
with 0.4 107 S. aureus inoculations on mice.11 Although
the data from Schmacht et al.15 showed that neither silver-
coated grafts nor rifampicin-soaked grafts eradicated
S. aureus totally, the rifampicin grafts had a significantly
antibacterial effect. In summary, these studies have shown
that nearly all of silver-coated vascular grafts were still
infected after S. aureus inoculations and this indicates that
silver-coated vascular graft could not prevent PVGI.
Our results seem inconsistent with some of the in vivo
experiments.12,13 The reasons for the differences between
in vitro and in vivo studies may be attributed to the
decreased antimicrobial activity of silver ions in biologic
environments and minimal leaching or non-leaching from
the silver-coated surfaces. First, in vivo, the blood proteins
deposited onto the surface of graft, such as albumin, may
bind the silver ions that lead to inactivation of anti-
microorganisms.16 Second, the chloride ion in the body can
convert silver acetate, which is the most common
compound used for coating the vascular graft surface, to
silver chloride that may reduce the efficacy of silver ions
due to insolubility.14 In addition, minimal leaching or non-
leaching of silver from the silver-coated graft could
preclude the silver ions to leach out into the tissues causing
failure of antibacterial activity in the tissue around the
implant site.9 These factors may have contributed to the
lack of antimicrobial efficacy of the silver-coated vascular
grafts in our study. However, Schmacht et al.15 suggested
that the silver-coated graft combined with antibiotic
therapy may indeed be more successful in bacterial inhi-
bition than silver-coated grafts alone. Although some
papers17e20 presented similar results, the effectiveness of
combined silver-antibiotic-coated grafts to prevent graft
infection needs further investigation.
In conclusion, silver-coated polyester graft failed to
prevent aortic graft infection after inoculation with 106
CFUs of S. aureus in 0.3 ml suspension in a porcine model.
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